Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Multiple Sclerosis

• Publication date

  2007-01-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1352458506070758PMID 17439882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gray and white matter volume changes in early RRMS

  2005cited by this paper
• The multiple sclerosis functional composite: different practice effects in the three test components.

  2005cited by this paper
• Axonal injury in multiple sclerosis

  2003cited by this paper
• Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

  2003cited by this paper
• Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

  2002cited by this paper
• Is Gadolinium Enhancement Predictive of the Development of Brain Atrophy in Multiple Sclerosis? A Review of the Literature

  2002cited by this paper
• A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.

  2002cited by this paper
• Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

  2002influential reference
• Multiple sclerosis.

  2002cited by this paper
• Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions

  2001cited by this paper
• Ring-enhancement in multiple sclerosis: marker of disease severity

  2001cited by this paper
• Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.

  2001cited by this paper
• The predictive value of gadolinium enhancement for long term disability in relapsing-remitting multiple sclerosis-preliminary results

  2001cited by this paper
• A modified protocol to improve the detection of enhancing brain and spinal cord leasions in multiple sclerosis

  2001cited by this paper
• Enhanced magnetic resonance imaging in multiple sclerosis

  2000cited by this paper
• Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis

  2000cited by this paper
• Temporal Development of Autoreactive Th1 Responses and Endogenous Presentation of Self Myelin Epitopes by Central Nervous System-Resident APCs in Theiler’s Virus-Infected Mice1

  2000cited by this paper
• The effect of gadolinium-enhancing lesions on whole brain atrophy in relapsing-remitting MS

  2000cited by this paper
• Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans.

  1999cited by this paper
• Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images.

  1999cited by this paper
• Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

  1999cited by this paper
• Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

  1999cited by this paper
• Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium

  1998cited by this paper
• Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis

  1998cited by this paper
• Axonal transection in the lesions of multiple sclerosis.

  1998cited by this paper
• A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.

  1998cited by this paper
• Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions.

  1997cited by this paper
• Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis.

  1997cited by this paper
• Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.

  1997cited by this paper
• Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology

  1997cited by this paper
• Defining the clinical course of multiple sclerosis

  1996cited by this paper
• Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis

  1996cited by this paper
• Blood‐brain barrier disruption on contrast‐enhanced MRI in patients with mild relapsing‐remitting multiple sclerosis

  1995cited by this paper
• Longitudinal MRI in multiple sclerosis

  1994cited by this paper
• Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

  1993cited by this paper
• Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions

  1993cited by this paper
• Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

  1992cited by this paper
• Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration

  1992cited by this paper
• Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.

  1992cited by this paper
• Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

  1991cited by this paper
• The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.

  1989cited by this paper
• Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.

  1988cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper
• Rating neurologic impairment in multiple sclerosis

  1983influential reference
• Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis (MS).

  1981cited by this paper
• SHORT-TERM EVOLUTION OF NEW MULTIPLE SCLEROSIS LESIONS ENHANCING

  year unknowncited by this paper

• Esclerosis múltiple altamente activa y su influencia en la elección del tratamiento

  2021cites this paper
• Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course

  2016cites this paper
• Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome

  2015cites this paper
• Perfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status

  2014cites this paper
• Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010.

  2012cites this paper
• Recommendations for a definition of multiple sclerosis in support of early treatment.

  2012cites this paper
• Clinical consequences of MRI activity in treated multiple sclerosis

  2011cites this paper
• Understanding progression in primary progressive multiple sclerosis: a longitudinal clinical and magneticresonance imaging study

  2010cites this paper
• Electrophysiological and clinical correlates of corpus callosum atrophy in patients with multiple sclerosis

  2010cites this paper
• The investigation of early MRI in diagnosis and prognosis in patients presenting with a clinically isolated syndrome characteristic of demyelination

  2009influential citation
• Évaluation de l'atrophie et de la charge lésionnelle sur des séquences IRM de patients atteints de sclérose en plaques

  2009cites this paper
• Early MRI in optic neuritis

  2009cites this paper
• Imaging patterns of inflammation in multiple sclerosis: a multifocal approach

  2009cites this paper
• High-molar contrast agents for CNS application

  2008cites this paper
• Longitudinal imaging: change and causality

  2008cites this paper
• MRI in multiple sclerosis: What’s inside the toolbox?

  2007cites this paper